Literature DB >> 23731716

Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis.

Murat Topuzogullari1, Rabia Cakir Koc, Sevil Dincer Isoglu, Melahat Bagirova, Zeynep Akdeste, Serhat Elcicek, Olga N Oztel, Serap Yesilkir Baydar, Sezen Canim Ates, Adil M Allahverdiyev.   

Abstract

Research on the conjugates of synthetic polyelectrolytes with antigenic molecules, such as proteins, peptides, or carbohydrates, is an attractive area due to their highly immunogenic character in comparison to classical adjuvants. For example, polyacrylic acid (PAA) is a weak polyelectrolyte and has been used in several biomedical applications such as immunological studies, drug delivery, and enzyme immobilization. However, to our knowledge, there are no studies that document immune-stimulant properties of PAA in Leishmania infection. Therefore, we aimed to develop a potential vaccine candidate against leishmaniasis by covalently conjugating PAA with an immunologically vital molecule of lipophosphoglycan (LPG) found in Leishmania parasites. In the study, LPG and PAA were conjugated by a multi-step procedure, and final products were analyzed with GPC and MALDI-TOF MS techniques. In cytotoxicity experiments, LPG-PAA conjugates did not indicate toxic effects on L929 and J774 murine macrophage cells. We assume that LPG-PAA conjugate can be a potential vaccine candidate, and will be immunologically characterized in further studies to prove its potential.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23731716      PMCID: PMC3682889          DOI: 10.1186/1423-0127-20-35

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  16 in total

1.  New advances in microsphere-based single-dose vaccines.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-10-13       Impact factor: 15.470

2.  [Study of the mechanisms of the action of heparin and poly-4-vinylpyridine on immunogenesis].

Authors:  R V Petrov; A N Gvozdetskiĭ; A A Gorokhov; V P Evdakov; V A Kabanov
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1974-11

3.  Safety and efficacy of an inactivated Carbopol-adjuvanted goose haemorrhagic polyomavirus vaccine for domestic geese.

Authors:  Jacqueline Gelfi; Michael Pappalardo; Carine Claverys; Brigitte Peralta; Jean-Luc Guerin
Journal:  Avian Pathol       Date:  2010-04       Impact factor: 3.378

4.  Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions.

Authors:  A B Mahoney; D L Sacks; E Saraiva; G Modi; S J Turco
Journal:  Biochemistry       Date:  1999-08-03       Impact factor: 3.162

5.  Immunogenic Cu2+-induced biopolymer systems comprising a steroid hormone, protein antigen, and synthetic polyelectrolytes.

Authors:  Aynur Başalp; Zeynep Mustafaeva; Mamed Mustafaev
Journal:  Hybrid Hybridomics       Date:  2002-02

6.  Quantitation of Leishmania lipophosphoglycan repeat units by capillary electrophoresis.

Authors:  Tamara L Barron; Salvatore J Turco
Journal:  Biochim Biophys Acta       Date:  2005-11-08

7.  Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity.

Authors:  Alexander K Andrianov; Alexander Marin; Bryan E Roberts
Journal:  Biomacromolecules       Date:  2005 May-Jun       Impact factor: 6.988

8.  Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.

Authors:  George Krashias; Anna-Katharina Simon; Frank Wegmann; Wai-Ling Kok; Ling-Pei Ho; David Stevens; John Skehel; Jonathan L Heeney; Amin E Moghaddam; Quentin J Sattentau
Journal:  Vaccine       Date:  2010-02-02       Impact factor: 3.641

9.  Alkyl-esters of polyacrylic acid as vaccine adjuvants.

Authors:  L A Hilgers; I Nicolas; G Lejeune; E Dewil; M Strebelle; B Boon
Journal:  Vaccine       Date:  1998-10       Impact factor: 3.641

Review 10.  Leishmaniasis: current situation and new perspectives.

Authors:  P Desjeux
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.268

View more
  8 in total

Review 1.  Identifying vaccine targets for anti-leishmanial vaccine development.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Vaccines       Date:  2014-04       Impact factor: 5.217

2.  A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.

Authors:  Vivian T Martins; Mariana C Duarte; Miguel A Chávez-Fumagalli; Daniel Menezes-Souza; Cecília S P Coelho; Danielle F de Magalhães-Soares; Ana Paula Fernandes; Manuel Soto; Carlos A P Tavares; Eduardo A F Coelho
Journal:  Parasit Vectors       Date:  2015-07-11       Impact factor: 3.876

3.  Synthesis and characterization of antigenic influenza A M2e protein peptide-poly(acrylic) acid bioconjugate and determination of toxicity in vitro.

Authors:  Yasemin Budama Kilinc; Zeynep Mustafaeva Akdeste; Rabia Cakir Koc; Melahat Bagirova; Adil Allahverdiyev
Journal:  Bioengineered       Date:  2014-11-11       Impact factor: 3.269

Review 4.  The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses.

Authors:  Anand Kumar Gupta; Sonali Das; Mohd Kamran; Sarfaraz Ahmad Ejazi; Nahid Ali
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

Review 5.  Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?

Authors:  Claire-Lise Forestier; Qi Gao; Geert-Jan Boons
Journal:  Front Cell Infect Microbiol       Date:  2015-01-21       Impact factor: 5.293

Review 6.  Parasite Carbohydrate Vaccines.

Authors:  Jonnel A Jaurigue; Peter H Seeberger
Journal:  Front Cell Infect Microbiol       Date:  2017-06-12       Impact factor: 5.293

7.  A Novel Chimeric Antigen as a Vaccine Candidate against Leishmania major: In silico Analysis.

Authors:  Niloofar Bavarsad Ahmadpour; Abdolhossein Dalimi; Majid Pirestani; Javid Sadraei
Journal:  Iran J Parasitol       Date:  2021 Apr-Jun       Impact factor: 1.012

8.  Synthesis and antileishmanial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives.

Authors:  Yihenew Simegniew Birhan; Adnan Ahmed Bekhit; Ariaya Hymete
Journal:  Org Med Chem Lett       Date:  2014-09-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.